SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : CYTC - How High Can It Go!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: reggie jackson who wrote (136)12/14/1998 8:23:00 PM
From: Gator II  Read Replies (1) of 185
 
ThinPrep was highlighted in a piece on Women's Healthcare tonight on NBC's Evening News. It was, IMO, a balanced piece with a doctor from Vanderbilt in essence saying the jury was still out as to whether ThinPrep was cost effective (suggesting the add'l cost of ThinPrep v. the conventional pap could be better spent on getting women who don't currently receive a pap yearly to do so) and a women who reads Paps strongly suggesting that without ThinPrep her own cervical cancer would not have been detected in time. It was a powerful piece, albeit short, that should help CYTC's stock price tomorrow. It should have left no question in the viewer's mind that ThinPrep was SUPERIOR to the conventional Pap. I doubt if many enlightened women would choose a conventional pap for fifteen or twenty dollars less over ThinPrep. If they did, I would conclude they were in a word, stupid.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News